-+ 0.00%
-+ 0.00%
-+ 0.00%

Bicara Therapeutics President and COO Ryan Cohlhepp reports disposal of USD 817,447.74 common shares

PUBT·07/10/2026 20:12:07
Listen to the news
Bicara Therapeutics President and COO Ryan Cohlhepp reports disposal of USD 817,447.74 common shares
  • Bicara Therapeutics President, COO, director Ryan Cohlhepp cut his direct common-stock stake to 181,641 shares.
  • Sold 28,750 shares on July 8-9 at prices around USD 28.76 to USD 30.35.
  • Exercised options for 18,750 shares at USD 3.79 on July 8.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bicara Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001470831-26-000701), on July 10, 2026, and is solely responsible for the information contained therein.